Overexpression of DDX49 in prostate cancer is associated with poor prognosis by Junyue Tao, Qintao Ge, Jialing Meng, Chaozhao Liang, Zongyao Hao, Jun Zhou

Get full text

Landscape of the intratumroal microenvironment in bladder cancer: Implications for prognosis and immunotherapy by Zichen Bian, Jia Chen, Chang Liu, Qintao Ge, Meng Zhang, Jialin Meng, Chaozhao Liang

Get full text

Deciphering the suppressive immune microenvironment of prostate cancer based on CD4+ regulatory T cells: Implications for prognosis and therapy prediction by Qintao Ge, Zhijie Zhao, Xiao Li, Feixiang Yang, Meng Zhang, Zongyao Hao, Chaozhao Liang, Jialin Meng

Get full text

Molecular classifications of prostate cancer: basis for individualized risk stratification and precision therapy by Qintao Ge, Jiawei Li, Feixiang Yang, Xuefeng Tian, Meng Zhang, Zongyao Hao, Chaozhao Liang, Jialin Meng

Get full text

Insights from immunomics and metabolomics on the associations between prostatic diseases and coronavirus disease 2019 by Feixiang Yang, Peng Guo, Kun Wang, Xiangyu Zhang, Zhehao Hu, Qiyue Lou, Qintao Ge, Yiding Chen, Chaozhao Liang, Jialin Meng

Get full text

Integrated analysis of histone modification features in clear cell renal cancer for risk stratification and therapeutic prediction by Wenming Ma, Qintao Ge, Yu Guan, Li Zhang, Liqun Huang, Lei Chen, Wenlong Xu, Jialin Meng, Guosheng Yang, Chaozhao Liang

Get full text

Integrated multi‐omics data reveals the molecular subtypes and guides the androgen receptor signalling inhibitor treatment of prostate cancer by Jialin Meng, Xiaofan Lu, Chen Jin, Yujie Zhou, Qintao Ge, Jun Zhou, Zongyao Hao, Fangrong Yan, Meng Zhang, Chaozhao Liang

Get full text

Multiomics characterization and verification of clear cell renal cell carcinoma molecular subtypes to guide precise chemotherapy and immunotherapy by Jialin Meng, Aimin Jiang, Xiaofan Lu, Di Gu, Qintao Ge, Suwen Bai, Yundong Zhou, Jun Zhou, Zongyao Hao, Fangrong Yan, Linhui Wang, Haitao Wang, Juan Du, Chaozhao Liang

Get full text